ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2885

Expansion of Activated PD-1+ ICOS+ T Follicular and Peripheral Helper Cells in Primary Sjögren’s Syndrome Associates with Abnormalities in B Cell Compartment

Nida Meednu1, Jennifer Albrecht2, Madhu Ramaswamy3, Jeffrey Riggs4, Alex Rosenberg5, Jamie Biear6, Ralf G. Thiele7, Andreea Coca2, Gianluca Carlesso3 and Jennifer Anolik2, 1Medicine- Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY, 2University of Rochester Medical Center, Rochester, NY, 3MedImmune LLC, Gaithersburg, MD, 4Respiratory, Inflammation and Autoimmunity (RIA), MedImmune LLC, Gaithersburg, MD, 5University of Alabama at Birmingham, Birmingham, AL, 6Rheumatology, University of Rochester Medical Center, Rochester, NY, 7Division of Rheumatology, University of Rochester Medical Center, Rochester, NY

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: B cells, Sjogren's syndrome and T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: 5T110 ACR Abstract: Sjögren's Syndrome–Basic & Clinical Science (2880–2885)

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Primary Sjögren’s syndrome (pSS) is a systemic autoimmune disease characterized by immune cell infiltration in the salivary glands resulting in ocular and oral dryness. Abnormalities in both B and T follicular helper (Tfh) cells associated with ectopic germinal center formation in the salivary gland has been described in pSS. However, the diversity of Tfh cells and relationship between B and T cell subsets has not been fully elucidated. In this study, we examined the expression of ICOS and PD-1, two critical immune co-regulatory molecules for T follicular helper function, on memory T cells in both CXCR5+ (Tfh) and CXCR5– (Tph) populations in pSS compared to HC, SLE and RA. We evaluated changes in peripheral blood B and T cell populations in pSS compared to other diseases and healthy controls.

Methods: pSS, SLE and RA patients, along with age and gender matched HC were recruited at University of Rochester. pSS (n=40), SLE (n=19) and RA (n=20) were classified based on ACR criteria. PBMCs were isolated by Ficoll-Hypaque and the frequencies of B and T subpopulations measured by multi-parameter flow cytometry. The mean+/- SEM was calculated for each cell population and statistical analysis was done by t-test. Correlation analysis was done by Pearson method, p < 0.05 was considered significant.

Results: pSS and SLE had significantly higher frequency of both CXCR5+PD-1+ICOS+ (PD-1+ICOS+ Tfh) and CXCR5–PD-1hiICOS+ (ICOS+ Tph) than HC, while RA and SLE had higher percent of CXCR5–PD-1hi (Tph) than HC. Further evaluation of Tfh subsets (based on CXCR3 and CCR6), revealed higher frequency of PD-1+ICOS+ Tfh1 and PD-1+ICOS+ Tfh2 in pSS and SLE compared to HC. In addition, we evaluated PD-1+ICOS– Tfh populations that have been shown to have B cell helper functions. PD-1+ICOS– Tfh1 and PD-1+ICOS– Tfh2 were expanded in pSS and RA compared to HC, while RA patients also showed expansion of PD-1+ICOS– Tfh17. Characterization of B cells in pSS patients revealed significant contractions of switched memory (SM), un-switched memory (USM) and double negative memory (DN) B cell compared to HC. In contrast, the fraction of activated memory B cells (CD95+ or CD21-) was significantly higher in pSS compared to HC. Additionally, the frequency of activated CD27+ memory B cell were positively correlated with frequency of PD-1+ICOS+ Tfh and ICOS+ Tph. The frequency of ICOSL+ B cells was positively associated with the frequency of PD-1+ICOS– Tfh17 (r=0.362, p=0.024), a putative B cell helper Tfh subset. We are currently evaluating transcriptomic and proteomic data from these patients to correlate with flow cytometry data and to further elucidate the interaction between the B cell and T cell compartment in pSS.

Conclusion: Our data highlight the significant abnormalities in the peripheral Tfh and B cell compartment in pSS and the critical role of Tfh-B cell interactions. The association between ICOSL+ memory B cells and ICOS+ T cells suggests their potential interaction in germinal center-like structures in salivary glands.


Disclosure: N. Meednu, None; J. Albrecht, None; M. Ramaswamy, MedImmune, LLC, 3; J. Riggs, Medmmune, LLC, 3; A. Rosenberg, None; J. Biear, None; R. G. Thiele, AbbVie Inc., 8,Amgen Inc., 8; A. Coca, None; G. Carlesso, MedImmune, LLC, 3; J. Anolik, None.

To cite this abstract in AMA style:

Meednu N, Albrecht J, Ramaswamy M, Riggs J, Rosenberg A, Biear J, Thiele RG, Coca A, Carlesso G, Anolik J. Expansion of Activated PD-1+ ICOS+ T Follicular and Peripheral Helper Cells in Primary Sjögren’s Syndrome Associates with Abnormalities in B Cell Compartment [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/expansion-of-activated-pd-1-icos-t-follicular-and-peripheral-helper-cells-in-primary-sjogrens-syndrome-associates-with-abnormalities-in-b-cell-compartment/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/expansion-of-activated-pd-1-icos-t-follicular-and-peripheral-helper-cells-in-primary-sjogrens-syndrome-associates-with-abnormalities-in-b-cell-compartment/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology